Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab +/- Paclitaxel in Advanced Urothelial Cancer
NCT00350025Phase 2Completed
- Sponsor
- Fox Chase Cancer Center
- Start
- Aug 2006
- Primary completion
- Jul 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in urothelial carcinoma (UC), sponsored by Fox Chase Cancer Center. Started Aug 2006; status: completed.
02
Drugs
KL-140
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00350025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350025.